A Human Ex-Vivo Contractility-Based Assay for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-Arrhythmia Risk.

By | 2017-10-26T20:17:50+00:00 March 16th, 2017|

Thursday, March 16th from 8:30 am to 11:45 am:

“A Human Ex-Vivo Contractility-Based Assay for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-Arrhythmia Risk.” Hall A of the Exhibit Hall (Dr. Najah Abi-Gerges).

If you will be at the meeting in March, please contact Alisen James: ajames@anabios.com, to let us know. We forward to connecting with both colleagues and clients.